T helper 17 cells play a critical pathogenic role in lung cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 15, 2014, Pages 5664-5669

  Chang, Seon Hee ^a   Mirabolfathinejad, Seyedeh Golsar ^a   Katta, Harshadadevi ^a   Cumpian, Amber M ^a   Gong, Lei ^a   Caetano, Mauricio S ^a   Moghaddam, Seyed Javad ^a   Dong, Chen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Interleukin 17; Lung adenocarcinoma

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; K RAS PROTEIN; SECRETORY PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GAMMA DELTA T LYMPHOCYTE; HAEMOPHILUS INFLUENZAE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; LUNG CARCINOGENESIS; LUNG LAVAGE; LYMPHOCYTE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TUMOR VASCULARIZATION;

INTERLEUKIN 17; LUNG ADENOCARCINOMA;

ANIMALS; DNA PRIMERS; FLOW CYTOMETRY; GENES, RAS; HAEMOPHILUS INFLUENZAE; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MICE, MUTANT STRAINS; MUTATION; MYELOID CELLS; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; TH17 CELLS; UTEROGLOBIN;

EID: 84898777944     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1319051111     Document Type: Article

References (46)

1. Elinav E, et al. (2013) Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13(11):759-771
2. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883-899
3. Spitz MR, et al. (2007) A risk model for prediction of lung cancer. J Natl Cancer Inst 99(9):715-726
4. Celli BR (2012) Chronic obstructive pulmonary disease and lung cancer: Common pathogenesis, shared clinical challenges. Proc Am Thorac Soc 9(2):74-79
5. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12(4):253-268
6. Fridman WH, Pages F, Sautes-Fridman C, Galon J (2012) The immune contexture in human tumours: Impact on clinical outcome. Nat Rev Cancer 12(4):298-306
7. Takahashi H, Ogata H, Nishigaki R, Broide DH, Karin M (2010) Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta-And JNK1-dependent inflammation. Cancer Cell 17(1):89-97
8. Meylan E, et al. (2009) Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 462(7269):104-107
9. Park H, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6(11):1133-1141
10. Harrington LE, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6(11): 1123-1132
11. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21(4):467-476
12. Kryczek I, et al. (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114(6):1141-1149
13. Reppert S, et al. (2011) A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer. Nat Commun 2:600
14. Chen X, et al. (2010) Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer 69(3):348-354
15. Hamai A, et al. (2012) Human T(H)17 immune cells specific for the tumor antigen MAGE-A3 convert to IFN-gamma-secreting cells as they differentiate into effector T cells in vivo. Cancer Res 72(5):1059-1063
16. Martin-Orozco N, Dong C (2009) The IL-17/IL-23 axis of inflammation in cancer: Friend or foe? Curr Opin Investig Drugs 10(6):543-549
17. Chae WJ, et al. (2010) Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci USA 107(12):5540-5544
18. Wu S, et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15(9):1016-1022
19. Grivennikov SI, et al. (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491(7423):254-258
20. Tong Z, et al. (2012) A protective role by interleukin-17F in colon tumorigenesis. PLoS ONE 7(4):e34959
21. Kryczek I, Wei S, Szeliga W, Vatan L, Zou W (2009) Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 114(2):357-359
22. Wang L, et al. (2009) IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 206(7):1457-1464
23. Martin-Orozco N, et al. (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31(5):787-798
24. Muranski P, et al. (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112(2):362-373
25. Moghaddam SJ, et al. (2009) Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model. Am J Respir Cell Mol Biol 40(4):443-453
26. Jackson EL, et al. (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15(24):3243-3248
27. Li H, et al. (2008) Cre-mediated recombination in mouse Clara cells. Genesis 46(6): 300-307
28. Ji H, et al. (2006) K-ras activation generates an inflammatory response in lung tumors. Oncogene 25(14):2105-2112
29. Bandi V, et al. (2001) Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 164(11):2114-2119
30. Corzo CA, et al. (2010) HIF-1alpha regulates function and differentiation of myeloidderived suppressor cells in the tumor microenvironment. J Exp Med 207(11):2439-2453
31. Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359(13): 1367-1380
32. Zhang Q, et al. (2012) Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models. Cancer Res 72(10):2589-2599
33. Maniati E, Hagemann T (2013) IL-17 mediates resistance to anti-VEGF therapy. Nat Med 19(9):1092-1094
34. Blatner NR, et al. (2012) Expression of RORgammat marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med 4(164):ra159
35. Benchetrit F, et al. (2002) Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 99(6):2114-2121
36. Acharyya S, et al. (2012) A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150(1):165-178
37. Wislez M, et al. (2006) High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res 66(8):4198-4207
38. Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D (2012) Oncogenic Krasinduced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21(6):836-847
39. Bayne LJ, et al. (2012) Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21(6):822-835
40. Murdoch C, Muthana M, Coffelt SB, Lewis CE (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8(8):618-631
41. Gong L, et al. (2013) Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase. Mol Cancer 12(1):154
42. Shan M, et al. (2009) Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Sci Transl Med 1(4):ra10
43. Shan M, et al. (2012) Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med 4(117):ra119
44. Chen K, et al. (2011) IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS ONE 6(5):e20333
45. Ying H, et al. (2012) Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149(3):656-670
46. Yang XXO, et al. (2008) Regulation of inflammatory responses by IL-17F. J Exp Med 205(5):1063-1075.